MORGAN STANLEY - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$811,391
-21.7%
78,244
+8.1%
0.00%
Q2 2023$1,036,511
+54.9%
72,382
-22.7%
0.00%
Q1 2023$669,003
-13.8%
93,698
+35.4%
0.00%
Q4 2022$776,290
-24.3%
69,188
-25.1%
0.00%
Q3 2022$1,025,000
+11.5%
92,430
-15.1%
0.00%
Q2 2022$919,000
-20.2%
108,862
+28.7%
0.00%
Q1 2022$1,151,000
-58.0%
84,600
-39.2%
0.00%
Q4 2021$2,738,000
+219.5%
139,168
+420.6%
0.00%
Q3 2021$857,000
-4.4%
26,733
+0.9%
0.00%
Q2 2021$896,000
+44700.0%
26,492
+44801.7%
0.00%
Q1 2021$2,000
-99.2%
59
-99.3%
0.00%
Q4 2020$264,000
+560.0%
7,933
+624.5%
0.00%
Q3 2020$40,000
-63.6%
1,095
-67.1%
0.00%
Q2 2020$110,000
+423.8%
3,332
+300.5%
0.00%
Q1 2020$21,000
-95.3%
832
-94.2%
0.00%
Q4 2019$450,00014,4410.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders